Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017.

Emerging Infectious Diseases
Hyukmin LeeKyungwon Lee

Abstract

In South Korea, surveillance of antimicrobial drug resistance in Neisseria gonorrhoeae is extremely limited. We describe the emergence and subsequent national spread of N. gonorrhoeae strains with mosaic penA alleles associated with decreased susceptibility and resistance to extended-spectrum cephalosporins. From 2012 through 2017, the proportion of mosaic penA alleles in gonococcal-positive nucleic acid amplification test (NAAT) specimens across South Korea increased from 1.1% to 23.9%. Gonococcal strains with mosaic penA alleles emerged in the international hubs of Seoul in Gyeonggi Province and Busan in South Gyeongsang Province and subsequently spread across South Korea. Most common was mosaic penA-10.001 (n = 572 isolates; 94.7%), which is associated with cefixime resistance. We also identified mosaic penA-34.001 and penA-60.001, both of which are associated with multidrug-resistant gonococcal strains and spread of cefixime and ceftriaxone resistance. Implementation of molecular resistance prediction from N. gonorrhoeae-positive nucleic acid amplification test specimens is imperative in South Korea and internationally.

References

Apr 10, 2004·The Journal of Infectious Diseases·Iona M C MartinBrian G Spratt
Jun 17, 2009·Antimicrobial Agents and Chemotherapy·Shuqing ZhaoRobert A Nicholas
Feb 10, 2012·The New England Journal of Medicine·Gail A BolanJudith N Wasserheit
Dec 13, 2012·Future Microbiology·Magnus Unemo, Robert A Nicholas
Apr 19, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·N GoireD M Whiley
Jan 9, 2014·International Journal of STD & AIDS·C BignellUNKNOWN European STI Guidelines Editorial Board
Feb 11, 2014·Nature Reviews. Microbiology·Namraj GoireDavid M Whiley
Jul 2, 2014·Clinical Microbiology Reviews·Magnus Unemo, William M Shafer
Nov 6, 2014·The New England Journal of Medicine·Monica M LahraDavid M Whiley
Mar 31, 2015·Future Microbiology·David M WhileyMagnus Unemo
Nov 4, 2015·JAMA : the Journal of the American Medical Association·Robert D KirkcaldyJohn R Papp
Dec 15, 2015·Current Opinion in Infectious Diseases·Nicola Low, Magnus Unemo
Dec 23, 2015·Emerging Infectious Diseases·Takashi DeguchiMutsumasa Yoh
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Shu-Ichi NakayamaMakoto Ohnishi
Jun 23, 2016·The New England Journal of Medicine·Helen FiferMagnus Unemo
Oct 27, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·David TerkelsenHenrik Westh
May 20, 2018·The Lancet Infectious Diseases·Simon R HarrisUNKNOWN Euro-GASP study group
May 31, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Thibault PoncinBeatrice Bercot
Jul 12, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·David W EyreMonique I Andersson
Nov 30, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Daniel GolparianMagnus Unemo

❮ Previous
Next ❯

Citations

Dec 17, 2019·Journal of Travel Medicine·Vivian TienMarisa K Holubar
Jun 23, 2021·Nature Communications·Jesse C ThomasUNKNOWN Antimicrobial Resistant Neisseria gonorrhoeae Working Group

❮ Previous
Next ❯

Methods Mentioned

BETA
and
PCR
nucleic acid amplification

Software Mentioned

NG
Statistica
MAST

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.